## 4 Market Approach and Discussion  
### Innovation and Commercialization Chances in a Multi-KETs Scenario  
In September 2009, the European Commission published its communication \"_Preparing for our future: Developing a common strategy for key enabling technologies in the EU_\" [110]. This strategy identifies the need for the EU to facilitate the industrial deployment of KETs in order to make its industries more innovative and globally competitive. KETs are one of the key factors in realizing the overall policy objectives of Europe 2020, due to the importance of these technologies for the competitiveness and innovation of European enterprises as well as for the development of sustainable products and processes [111]. In this context, Horizon 2020, the biggest Framework for Research and Innovation, has scheduled over 74 billion \(\epsilon\) for research funding focused on three fundamental pillars: 24.598 million \(\epsilon\) intended for Scientific Excellence, 31.748 million \(\epsilon\) for Society Challenges and 17.938 million \(\epsilon\) for Industrial Leadership. The last one aims to support SMEs in the industrial development and application of _KETs_, considered crucial accelerators for innovation and competitiveness [112].  
KETs have been selected according to economic criteria, capital intensity, technology intensity, and their value adding enabling role [113]. The six KETs are: Nanotechnology, Micro and Nano Electronics, Photonics, Advanced Materials, Biotechnology Industry and Advanced Manufacturing Systems [114]. Among them, Nanotechnology is one of the most promising KETs due to its economic and social growth  
Figure 10: Anperometries measured with the prototype with three current levels programmed (Reproduced from [60] with kind permission from Springer Science + Bussiness Media B.V).  
potential, since it has been considered the greatest impulse to technological and industrial development in the 21 st century and the resource for the next industrial revolution [115, 116, 117, 118].  
The integration of different Key Enabling Technologies (KETs) represents a vital activity in H2020. About one third of the budget assigned to KETs will go to supporting innovation projects integrating different KETs [119]. Cross-cutting KETs activities will in general include activities closer to market and applications. The global market volume in KETS are 646 billion euros and substantial growth expected is approx. 8% of EU GDP by 2015 [113]. In the Healthcare domain, short (2017) and medium (2020) perspectives of cross cutting KETs are shown in the Figure 11.  
The European Commission stated that the EU has very good research and development capacities in some key enabling technology areas, but it has not been as successful in translating these results into commercialized manufactured goods and services [110]. R&D projects implemented in FP6 and FP7 frameworks have successfully delivered a lot of new nanomedicines but few products onto the market. In this context, the Commission states that bridging the so called \"Valley of Death\" to upscale new KET technology based prototypes to commercial manufacturing, often constitutes a weak link in the successful use of KETs potential. This is meant to be the \"European Industrial Renaissance\" by covering the whole value chain from Lab-to-Market as the principal aim of H2020 [113].  
Figure 11: Fields for cross-cutting KETS developments in the Health and Healthcare Domain [113].